Moderna’s First mRNA Mpox Vaccine Beats Licensed Rival Shots In Early Testing

The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of mpox lesions in infected animals compared to Bavarian Nordic’s licensed vaccine, Jynneos.